Haemonetics

From Wikipedia, the free encyclopedia

Haemonetics
Type	Public (NYSE: HAE)
Founded	1971
Headquarters	Braintree, Massachusetts, USA
Key people	Brad Nutter, President and CEO Peter Allen, President, Donor Division Brian Concannon, President and COO, Global Markets Robert Ebbeling, Vice President, Operations Dr. Ulrich Eckert, President, Europe and Latin America Joseph Forish, VP, Human Resources Christopher Lindop, VP and CFO Alicia Lopez, General Counsel and VP, Administration Dr. Mark Popovsky, VP, Corporate Medical Director William Still, VP and GM, Nanoscience Business and Business Development
Industry	Computer software Healthcare Blood banking
Employees	1,400
Website	www.haemonetics.com

Haemonetics (NYSE: HAE) is a global provider of blood and plasma supplies and services. Founded in Braintree, Massachusetts in the 1970s, the company has expanded and has many offices located in 16 countries.

They started out producing the containers and bags required for blood collection. From there they have branched off to making the whole plasma collection station including the machine, supplies and software for plasma collection. They have recently acquired several companies in an effort to expand their services. These acquisitions include Canadian based Fifth Dimension (5D) Information Systems in order to gain entry into the blood and plasma software industry. Further acquisitions include Chicago based Arryx in July 2006,^[1] Information Data Management Inc. in January 2007,^[2] and Infonale in July 2007.^[3]

Haemonetics continued to increase its products and services with the planned acquisition of Haemoscope announced in October 2007.^[4]

On August 21, 2007, 5D and IDM were officially merged into a new subsidiary called Haemonetics Software Solutions.^[5] The employees at both Edmonton (5D) and Rosemont (IDM) continue to work from their respective offices.

Haemonetics products can be considered as belonging to two broad categories:

donor products (marketed to the blood donation industry, these include products that automate the blood donation process, automate the processing of blood, support pathogen inactivation and bacterial detection of blood, and test blood hematocrit),

and patient products (products are marketed to the surgical suite for blood loss management for patients. The products include surgical blood salvage (or "autotransfusion") devices, surgical field blood suction systems, and blood and patient warming systems).

The company employs more than 1,400 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas.